Kanawha Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.65M Buy
8,046
+553
+7% +$565K 0.63% 48
2026
Q1
$6.89M Buy
7,493
+843
+13% +$855K 0.49% 60
2025
Q4
$7.15M Sell
6,650
-40
-0.6% -$38.2K 0.49% 58
2025
Q3
$5.1M Buy
6,690
+1,482
+28% +$1.1M 0.35% 68
2025
Q2
$4.06M Buy
5,208
+623
+14% +$484K 0.3% 75
2025
Q1
$3.79M Buy
4,585
+997
+28% +$830K 0.29% 75
2024
Q4
$2.77M Buy
3,588
+1,308
+57% +$1.08M 0.22% 80
2024
Q3
$2.02M Buy
2,280
+198
+10% +$178K 0.15% 97
2024
Q2
$1.88M Buy
2,082
+733
+54% +$586K 0.15% 95
2024
Q1
$1.05M Buy
1,349
+74
+6% +$52.7K 0.08% 119
2023
Q4
$743K Buy
1,275
+25
+2% +$14.6K 0.07% 122
2023
Q3
$671K Sell
1,250
-110
-8% -$56.7K 0.07% 129
2023
Q2
$638K Buy
1,360
+9
+0.7% +$3.77K 0.06% 132
2023
Q1
$464K Sell
1,351
-49
-4% -$16.5K 0.04% 150
2022
Q4
$512K Buy
1,400
+123
+10% +$43.6K 0.05% 144
2022
Q3
$413K Sell
1,277
-50
-4% -$15.8K 0.05% 146
2022
Q2
$430K Buy
1,327
+58
+5% +$17.4K 0.04% 146
2022
Q1
$363K Hold
1,269
0.03% 165
2021
Q4
$350K Buy
1,269
+94
+8% +$23.8K 0.03% 174
2021
Q3
$271K Sell
1,175
-95
-7% -$23.4K 0.03% 187
2021
Q2
$291K Sell
1,270
-15
-1% -$3.01K 0.03% 184
2021
Q1
$240K Buy
1,285
+65
+5% +$12.7K 0.02% 189
2020
Q4
$206K Buy
+1,220
New +$182K 0.02% 198

Other funds holding LLY

Kanawha Capital Management's LLY Position: Q2 2026 in Review

Kanawha Capital Management increased its Eli Lilly (LLY) stake by 7.4% in Q2 2026, buying an estimated $565K and bringing the position to 8,046 shares worth $9.65M. The position accounts for 0.63% of the portfolio, ranked #48.

Kanawha Capital Management first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kanawha Capital Management held 8,046 shares of Eli Lilly worth $9.65M as of Q2 2026.
  • Kanawha Capital Management bought 553 Eli Lilly shares in Q2 2026, an estimated $565K.
  • Eli Lilly made up 0.63% of Kanawha Capital Management's portfolio in Q2 2026, its #48 holding.
  • Kanawha Capital Management first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kanawha Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.